Top Tweets for #Pitt23

almost 2 years ago

Today THE Pittsburgh Steelers start their 2024 Super Bowl run. FUCK the naysayers this is OUR YEAR 🚀 #HereWeGo #SteelersNation #PITT23-#ATL17

Tian Zhang, MD, MHS, FASCO (@tiansterzhangmd.bsky) @TiansterZhang

about 3 years ago

#BradleyCarthon @WinshipAtEmory with broad sweeping updates in #bladdercancer from neoadj, adj, and metastatic settings! Kudos to covering everything from #VESPER to Checkmate 274 to #JAVELINbladder to #EV103 cohort K results!! #Pitt23 @UPMC @UPMCHillmanCC

TiansterZhang's tweet photo. #BradleyCarthon @WinshipAtEmory with broad sweeping updates in #bladdercancer from neoadj, adj, and metastatic settings! Kudos to covering everything from #VESPER to Checkmate 274 to #JAVELINbladder to #EV103 cohort K results!!
#Pitt23 @UPMC @UPMCHillmanCC https://t.co/qYp2SPWTWg

Tian Zhang, MD, MHS, FASCO (@tiansterzhangmd.bsky) @TiansterZhang

about 3 years ago

Brilliant overview from biology to trials from @RamalingamMD @WinshipAtEmory on EGFR mutant refractory #lungcancer — great objectives to improve IO therapies for NSCLC in their SPORE program. #Pitt23 @UPMC @UPMCHillmanCC

$TiansterZhang's tweet photo. Brilliant overview from biology to trials from @RamalingamMD @WinshipAtEmory on EGFR mutant refractory #lungcancer — great objectives to improve IO therapies for NSCLC in their SPORE program. #Pitt23 @UPMC @UPMCHillmanCC https://t.co/66WTi7wPDC$

Tian Zhang, MD, MHS, FASCO (@tiansterzhangmd.bsky) @TiansterZhang

about 3 years ago

@ZPiotrowskaMD @MGHMedicine @MGHCancerCenter with #ASCO23 updates — #ADAURA, Aredo-Blakely, #TROPION trials! #Pitt23 @UPMC @UPMCHillmanCC

TiansterZhang's tweet photo. @ZPiotrowskaMD @MGHMedicine @MGHCancerCenter with #ASCO23 updates — #ADAURA, Aredo-Blakely, #TROPION trials!
#Pitt23 @UPMC @UPMCHillmanCC https://t.co/fw0msAqWeR

531

Tian Zhang, MD, MHS, FASCO (@tiansterzhangmd.bsky) @TiansterZhang

about 3 years ago

Beautiful summary of first line NSCLC treatments from @HosseinBorghaei! I’m absorbing so much lung cancer CME… #Pitt23 @UPMCHillmanCC @UPMC

TiansterZhang's tweet photo. Beautiful summary of first line NSCLC treatments from @HosseinBorghaei! I’m absorbing so much lung cancer CME…
#Pitt23 @UPMCHillmanCC @UPMC https://t.co/Oo83uz6NPV

Patrick Forde @FordePatrick

about 3 years ago

Dr. @HosseinBorghaei with a whistle stop tour of first line treatment of advanced NSCLC! @UPMCHillmanCC Pittsburgh Annual Cancer Symposium.

FordePatrick's tweet photo. Dr. @HosseinBorghaei with a whistle stop tour of first line treatment of advanced NSCLC! @UPMCHillmanCC Pittsburgh Annual Cancer Symposium. https://t.co/cyNs11065V

Tian Zhang, MD, MHS, FASCO (@tiansterzhangmd.bsky) @TiansterZhang

about 3 years ago

Hearing the newest and greatest on #smallcelllungcancer from @teekayowo — atezo-chemo success in front line but much ongoing for refractory disease including ADCs targeting DLL3 & B7-H3, bispecifics, and novel radioligands! #Pitt23 @UPMC @UPMCHillmanCC

$TiansterZhang's tweet photo. Hearing the newest and greatest on #smallcelllungcancer from @teekayowo — atezo-chemo success in front line but much ongoing for refractory disease including ADCs targeting DLL3 & B7-H3, bispecifics, and novel radioligands! #Pitt23 @UPMC @UPMCHillmanCC https://t.co/MKe5r1s9G1$

Tian Zhang, MD, MHS, FASCO (@tiansterzhangmd.bsky) @TiansterZhang

about 3 years ago

An insightful overview from @FordePatrick @HopkinsMedicine on where we are in #lungcancer — neoadj immunotherapy makes a difference. Learning all about Checkmate 816, AEGEAN, & Keynote 671 trials. #PITT23 @UPMCHillmanCC @UPMC